# Long‐term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open‐label extension study

Article · Christopher H. van Dyck, Reisa Anne Sperling, Keith A. Johnson, Shobha Dhadda, Michio Kanekiyo, David Li, Michelle Gee, Steven M. Hersch, Michael C. Irizarry, Lynn Darden Kramer

- Archive id: doi:10.1002/alz.70905
- Published: 2025-12-01
- Venue: Alzheimer s & Dementia
- DOI: https://doi.org/10.1002/alz.70905
- PMID: 41355080
- Citations: 54
- Source URL: https://doi.org/10.1002/alz.70905
- PDF: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70905
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Alzheimer's, Parkinson's & Neurodegeneration](https://space-kitty.com/topics/neurodegeneration)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.